Biotech Jim ...could you up date this list from August
Are U still in OMER and did you add FGEN ?
Have you looked at MYOK . They are scheduled to meet with the FDA about now . A key question is whether or not they will seek Break thru status as well as details on the EXPLORER-HCM ...possibly their pivotal study with peak VO2 as the primary endpt.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.